000 01605 a2200445 4500
005 20250514020433.0
264 0 _c20020204
008 200202s 0 0 eng d
022 _a0027-5107
024 7 _a10.1016/s0921-8777(01)00106-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrossmann, K F
245 0 0 _aS. cerevisiae has three pathways for DNA interstrand crosslink repair.
_h[electronic resource]
260 _bMutation research
_cDec 2001
300 _a73-83 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCisplatin
_xpharmacology
650 0 4 _aCross-Linking Reagents
_xpharmacology
650 0 4 _aDNA Damage
650 0 4 _aDNA Repair
_xgenetics
650 0 4 _aDNA, Fungal
_xdrug effects
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aDNA-Directed DNA Polymerase
_xgenetics
650 0 4 _aEndodeoxyribonucleases
650 0 4 _aEpistasis, Genetic
650 0 4 _aFungal Proteins
_xgenetics
650 0 4 _aFurocoumarins
_xpharmacology
650 0 4 _aMethoxsalen
_xpharmacology
650 0 4 _aNuclear Proteins
_xgenetics
650 0 4 _aRad51 Recombinase
650 0 4 _aS Phase
_xdrug effects
650 0 4 _aSaccharomyces cerevisiae
_xdrug effects
650 0 4 _aSaccharomyces cerevisiae Proteins
_xgenetics
700 1 _aWard, A M
700 1 _aMatkovic, M E
700 1 _aFolias, A E
700 1 _aMoses, R E
773 0 _tMutation research
_gvol. 487
_gno. 3-4
_gp. 73-83
856 4 0 _uhttps://doi.org/10.1016/s0921-8777(01)00106-9
_zAvailable from publisher's website
999 _c11652280
_d11652280